Adopting ADHD technology across the NHS helps tackle waiting list challenge
Supporting information and quotes
Supporting information
-
The impact of a computerised test of attention and activity (QbTest) on diagnostic decision-making in children and young people with suspected attention deficit hyperactivity disorder: single-blind randomised controlled trial, NIHR randomised control trial published in 2018.
-
A national evaluation of QbTest to support ADHD assessment: a real-world, mixed methods approach, published by BMC Health Services Research in 2024.
-
Implementation, readiness and resourcing: a practical guide to the adoption and spread of health innovation programmes (PDF only), published by the Health Innovation Network in 2023.
Quotes
"From the initial East Midlands pilot programme across 3 local NHS trusts, within a couple of years via the 15 Health Innovation Networks, we are close to 100 per cent implementation across the NHS in England, benefiting more than 70,000 children and young people and saving valuable NHS resources."
"The guidance from NICE (published in 2024) is key to driving ongoing adoption, and the rollout of QbTest is an example of the fantastic results of close and effective collaboration between research and innovation partners – working together to build an evidence base and then drive the implementation of technologies that transform patient outcomes, free up valuable clinical time, and generate NHS savings."
Nicole McGlennon, Managing Director of Health Innovation East Midlands.
"In October 2024 QbTest achieved the fantastic milestone of 1 million tests worldwide, and our collaboration with the health innovation networks has provided the basis for rapid expansion within and beyond England. It has been a key part of the jigsaw that has enabled us to benefit so many children and young people globally."
Tony Doyle, Managing Director, Qbtech.
"QbTest has revolutionised ADHD diagnosis for children and young people by offering an objective assessment tool that measures all 3 core components. Made possible through the collaboration in the East Midlands, this innovation has significantly reduced the time to diagnosis, providing families with quicker and more accurate assessments. This is a clear example of how partnership-driven innovation can lead to more efficient and effective healthcare solutions."
Professor Kamlesh Khunti, Director of NIHR ARC East Midlands and Professor of Primary Care, Diabetes and Vascular Medicine at the University of Leicester.
"It takes a certain amount of confidence and bravery for the industry to open their products up to independent evaluation, particularly when the findings may have huge influence on subsequent sales and revenue. Qbtech were confident in their product and it's fantastic to see the benefits that can arise from such industry-academic partnerships."
Dr Charlotte Hall, Principal Research Fellow, NIHR MindTech.
Contact details
Chris Taylor
Director of communications and engagement
Email: [email protected]
Generic email: [email protected]
ISBN: 978-1-4731-7058-2
This page was last updated: